Investor Presentaiton
Mid- to Long-term Growth Strategy Progressing Steadily
Win in
Selected
Markets
Offer
Comprehen-
sive Value in
Japan
Select growing segments and segments where
Terumo owns a competitive advantage
Interventional systems, neurovascular, alliance,
therapeutic apheresis
Leverage the leading position and pursue
growth opportunities
✓ Launched Ultimaster Tansei
in JP,EU, and Aisa
Made an agreement on acquisition of
Chinese DES company
The WEB aneurysm embolization system
supported by FDA committee
✓ Expanded investment in Terumo
Yamaguchi D&D
Progress of Growth strategy
in Japanese market
Accelerate
Innovation
Contribute to future of healthcare with
significant social impact
Advance core technologies and gain new
technologies
Inaugurated WW Inovation Center
in California, US
✓ Expanded early-stage R&D base
at West Coast, US
R&D for WEB, Kanshas and AdSpray
✓ Commenced R&D for remote monitoring
systems specified for chronic heart failure
TERUMO
Terumo Corporation
2018/11/8
1/13View entire presentation